Cresemba® and Zevtera®-related revenues rise by 24% to CHF 90.5 millionTotal revenue grows significantly by 36% to CHF 104.0 ...

OHSU researchers found that many of those who access the pill over the counter had previously used no contraceptive method at ...

Wegovy is the first GLP-1 drug approved to treat adults with metabolic dysfunction-associated steatohepatitis (MASH). An ...

DNA-MRD testing better predicted outcomes versus PET/CT scans for large B-cell lymphoma, leading to NCCN guideline updates ...

Actelion (($ALIOF)) announced an update on their ongoing clinical study. Actelion’s latest clinical study, officially titled A Prospective, ...

A new federal study is linking the ability to quit smoking with longer-term success from the grip of drug or alcohol ...

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer in imaging technologies for the early detection and monitoring of metabolic liver disease, today announced that its ongoing multisite pilot study ...

For World Breast Cancer Research Day medical experts are highlighting the importance of early detection and advancing research. The ongoing studies surrounding a certain, more aggressive type, of ...

The results support the potential for treatment de-escalation after hysterectomy for women with early-stage, ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.